General Practice Doctors in Offutt Afb, NE Accepting Medicare

4 General Practice doctors found. Showing 1 - 4

David Faith, General Practice Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-6077

Dr. Alexander Thomas Paras, DO, MPH General Practice Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-7346

Dr. John Michael Black, General Practice Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-232-9431    Fax: 402-294-9138

Nicholas J Pace, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-232-2273

News Archive

Researchers identify genome-wide locus for serious gastrointestinal condition in infants

Researchers have identified a new genome-wide significant locus (the place a gene occupies on a chromosome) for infantile hypertrophic pyloric stenosis (IHPS), a serious gastrointestinal condition associated with gastrointestinal obstruction, according to a study in the August 21 issue of JAMA. Characteristics of this locus also suggest the possibility of an inverse relationship between levels of circulating cholesterol in neonates and IHPS risk.

ZenBio, Inc. introduces GroPro™ Cell Culture Growth Supplement formulated 
to replace Bovine serum

ZenBio, Inc. industry leader in robust cell-based solutions, announced today the worldwide release of a new GroPro Cell Culture Growth Supplement...

Six-minute walking distance test effectively determines disease severity in COPD

The six-minute walking distance test, a test that measures a patient's ability to tolerate exercise and physical activity, is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease, according to a three-year global study of patients with COPD sponsored by drug manufacturer GlaxoSmithKline.

Tofacitinib improves disease activity and inhibits progression of joint damage in RA patients

A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX).

Read more Medical News

› Verified 5 days ago